As Britain prepares for another blistering heatwave, health authorities have issued a critical warning regarding the use of common painkillers, such as ibuprofen and naproxen, which may heighten the risk of sunburn. With temperatures set to reach a sweltering 36°C next week, the Medicines and Healthcare products Regulatory Agency (MHRA) has advised the public to exercise caution, particularly those on specific medications.
Rising Temperatures and Medication Risks
The MHRA’s warning comes as the UK grapples with its fifth heatwave of the summer, following record-breaking temperatures in July. The agency highlighted that certain medications can increase sensitivity to sunlight, making individuals more susceptible to burns. In addition to widely used painkillers, other drugs that may amplify sun sensitivity include antibiotics like doxycycline and tetracycline, acne medications such as isotretinoin, and antifungal agents including voriconazole.
Dr Alison Cave, chief safety officer at the MHRA, underscored the importance of hydration and sun safety, stating, “Some commonly used medicines can affect the body’s ability to stay hydrated, regulate temperature, or protect itself from sun exposure.” She emphasised the significance of basic precautions such as drinking plenty of water, avoiding direct sun during peak hours, and utilising protective clothing and sunscreen.
Vulnerable Populations at Greater Risk
The impact of heatwaves can be particularly pronounced among vulnerable groups, including older adults and those with chronic health conditions, especially heart and lung diseases. Individuals taking multiple prescriptions are also at increased risk of heat-related illnesses.
Dr Nick Broughton, NHS England’s national director for mental health, has previously cautioned patients on mental health medications to be vigilant during hot weather, as some can hinder the body’s cooling mechanisms. He advised that patients should not abruptly discontinue their medication and should consult their GP or pharmacist if they have concerns.
Important Safety Measures
As the UK faces a period of extreme heat, the public is urged to take proactive steps to mitigate the risks associated with medication and sun exposure. Here are key recommendations:
1. **Review Medication Information**: Check the patient information leaflet accompanying all medications for guidance on sun exposure and hydration. This information is also available online.
2. **Recognise Heat Stress Symptoms**: Be aware of signs indicating the body is struggling in the heat, such as dizziness, headaches, confusion, or reduced urination. Skin reactions, including redness or blistering after sun exposure, may also signal increased sensitivity due to medication.
3. **Consult Healthcare Professionals**: Individuals unsure about how their medications may interact with heat or sunlight should seek advice from a pharmacist or GP before making any changes to their prescribed regimen.
Why it Matters
The intersection of medication and extreme weather conditions underscores a significant public health concern. As climate change continues to influence weather patterns, the risks associated with medication use in heat become more pronounced. This situation highlights the necessity for ongoing public health education about medication safety during extreme weather events. Protecting vulnerable populations from heat-related illnesses is not just a matter of individual health; it is a collective responsibility that requires informed action and robust healthcare guidance.